-
Impact of Social Determinants of Health on Severe Maternal Morbidity and Pregnancy Outcomes
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in HER2-Positive Early Breast Cancer in China: A Post-Hoc Analysis of the FeDeriCa Trial
Mar 10, 2025, 14:00 PM -
National Assessment of Prostate and Colon Cancer Screening Using National Health Interview Survey (NHIS)
Mar 10, 2025, 14:00 PM -
Use of Diaries to Capture Patient-Reported Outcomes in FDA New Drug Approvals (2019-2023)
Mar 10, 2025, 14:00 PM -
The Economic Burden of Illness for Patients with Idiopathic Pulmonary Fibrosis Utilizing Treatment Cohorts: A US Retrospective Claims Study
Mar 10, 2025, 14:00 PM -
Analysis of Real-World Evidence Use Across FDA Submissions in 2022 and 2023
Mar 10, 2025, 14:00 PM -
Guidance for the Role of Key Opinion Leaders in the Identification and Validation of Treatment Effect Modifiers and Prognostic Variables in Indirect Treatment Comparisons
Mar 10, 2025, 14:00 PM -
Drivers of High ICERs in SMC Appraisals
Mar 10, 2025, 14:00 PM -
Trends in Use of Cost-Minimization Analyses in CDA-AMC Reimbursement Submissions
Mar 10, 2025, 14:00 PM -
Health Utility Changes After Biologic Induction Therapy in Patients with Varying Severity of Psoriasis
Mar 10, 2025, 14:00 PM -
Reliability and Validity of EuroQol-5 Dimensions-5 Levels in Patients with Hematologic Malignancies: A Cross-Sectional Study
Mar 10, 2025, 14:00 PM -
Hypophosphatasia (HPP) Patient & Caregiver Disease Burden, Quality of Life & Treatment Experience: A Mixed Methods Study Concept
Mar 10, 2025, 14:00 PM -
Cost-Utility Analysis and Value-Based Pricing of Digital Therapeutics for Pulmonary Rehabilitation in Patients With Chronic Respiratory Disease: A Multicenter Randomized Controlled Trial
Mar 10, 2025, 14:00 PM -
A Network Meta-Analysis of Triple Therapy Inhalers Used in Moderate to Severe Chronic Obstructive Pulmonary Disease
Mar 10, 2025, 14:00 PM -
A Longitudinal Year-by-Year Cost Analysis for Patients Diagnosed with Polycythemia Vera
Mar 10, 2025, 14:00 PM -
Potential Added Clinical Value of Polygenic Risk Scores in Risk Assessment of Atherosclerotic Cardiovascular Disease
Mar 10, 2025, 14:00 PM -
Public Health Impact and Cost-Effectiveness of Adjuvanted RSVPreF3 Vaccination in US Adults Aged 60 Years with Cardiopulmonary Disease
Mar 10, 2025, 14:00 PM -
Treatment Patterns in the Management of Vitiligo in a Colombian HMO During 2015-2023: A Real-World Data Study
Mar 10, 2025, 14:00 PM -
Integrating Metrics of Environmental Sustainability into Economic Evaluations: A Targeted Literature Review
Mar 10, 2025, 14:00 PM -
US Stakeholder Perspectives on Accumulators, Maximizers, and Alternative Funding Programs: Implications for Patient Affordability and Outcomes Research
Mar 10, 2025, 14:00 PM
